NovoCure Limited (NVCR) - יחס יתרת חוב לטווח ארוך להון

NovoCure Limited (NVCR) maintains high margins based on the implementation of TTFields, which enables effective market expansion through the sale of components. However, military conflicts could block international trials and disrupt equipment delivery. The current metric stands at 0.61. Price action on GURU.Markets confirms that the company's global business reach leaves it vulnerable to sanctions and trade barriers that complicate shipments from Asia.

This indicator compares long-term liabilities against the company's own funds, allowing for an assessment of the balance between financial stability and the use of leverage to scale the business. By analyzing the ratio of long-term debt to equity, an investor can determine how effectively NovoCure Limited (NVCR) finances the costly production of rental equipment to drive therapy expansion and future cash flow growth.